Propanc Health Group Shares Jump 22% - BrokerBank Securities Provides Insights

NEW YORK, Oct. 7, 2015 /PRNewswire/ -- Propanc Health Group Corp. (OTCQB: PPCH) shares closed at $.0426 yesterday, up 22%. Trading volume was over double the average at 11 million shares. PPCH shares have risen 90% since they hit a low of $.0225 On September 29th.

Our due diligence will show investors in Propanc Health Group Corp. information they need about the company's cancer treatment program to make their investment choices. Get our due diligence report at the link below.

http://bit.ly/-PPCH_Due_Diligence_Report

Copy and paste to browser may be required.

About Propanc Health Group Corp.

Propanc Health Group Corporation is a development stage healthcare company whose current focus is the development of new cancer treatments for patients with solid tumors such as pancreatic and colorectal cancer. Propanc was established in 2007 and located in Melbourne, Australia.

FORWARD-LOOKING DISCLAIMER

This report may contain certain forward-looking statements and information, as defined within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934, and is subject to the Safe Harbor created by those sections. This material contains statements about expected future events and/or financial results that are forward-looking in nature and subject to risks and uncertainties. Such forward-looking statements by definition involve risks, uncertainties and other factors, which may cause the actual results, performance or achievements of mentioned company to be materially different from the statements made herein.  

COMPLIANCE PROCEDURE   

Content is researched, written and reviewed on a best-effort basis. This release and report was prepared for informational purposes only.  Affiliated parties involved with producing and issuing this release have not been compensated in any form by any source.  A full disclaimer can be found by viewing due diligence. We are only human and may make mistakes. If you notice any errors or omissions, please notify us below.

A full disclaimer can be found by viewing the full analyst report.

If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at [email protected]. For any urgent concerns or inquiries please contact us at [email protected].   

BrokerBank Securities, Inc. is a member of the Financial Industry Regulatory Authority, CRD number #130116.

SOURCE BrokerBank Securities, Inc.

Related Links

http://www.brokerbanksecurities.com